Literature DB >> 16934848

Arachnid toxinology in Australia: from clinical toxicology to potential applications.

Graham M Nicholson1, Andis Graudins, Harry I Wilson, Michelle Little, Kevin W Broady.   

Abstract

The unique geographic isolation of Australia has resulted in the evolution of a distinctive range of Australian arachnid fauna. Through the pioneering work of a number of Australian arachnologists, toxinologists, and clinicians, the taxonomy and distribution of new species, the effective clinical treatment of envenomation, and the isolation and characterisation of the many distinctive neurotoxins, has been achieved. In particular, work has focussed on several Australian arachnids, including red-back and funnel-web spiders, paralysis ticks, and buthid scorpions that contain neurotoxins capable of causing death or serious systemic envenomation. In the case of spiders, species-specific antivenoms have been developed to treat envenomed patients that show considerable cross-reactivity. Both in vitro and clinical case studies have shown they are particularly efficacious in the treatment of envenomation by spiders even from unrelated families. Despite their notorious reputation, the high selectivity and potency of a unique range of toxins from the venom of Australian arachnids will make them invaluable molecular tools for studies of neurotransmitter release and vesicle exocytosis as well as ion channel structure and function. The venoms of funnel-web spiders, and more recently Australian scorpions, have also provided a previously untapped rich source of insect-selective neurotoxins for the future development of biopesticides and the characterisation of previously unvalidated insecticide targets. This review provides a historical viewpoint of the work of many toxinologists to isolate and characterise just some of the toxins produced by such a unique group of arachnids and examines the potential applications of these novel peptides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934848     DOI: 10.1016/j.toxicon.2006.07.025

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  8 in total

Review 1.  Working Up a Good Sweat - The Challenges of Standardising Sweat Collection for Metabolomics Analysis.

Authors:  Joy N Hussain; Nitin Mantri; Marc M Cohen
Journal:  Clin Biochem Rev       Date:  2017-02

Review 2.  Tick paralysis in Australia caused by Ixodes holocyclus Neumann.

Authors:  S Hall-Mendelin; S B Craig; R A Hall; P O'Donoghue; R B Atwell; S M Tulsiani; G C Graham
Journal:  Ann Trop Med Parasitol       Date:  2011-03

3.  Arachnids of medical importance in Brazil: main active compounds present in scorpion and spider venoms and tick saliva.

Authors:  Francielle A Cordeiro; Fernanda G Amorim; Fernando A P Anjolette; Eliane C Arantes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-08-13

Review 4.  Venomous and poisonous Australian animals of veterinary importance: a rich source of novel therapeutics.

Authors:  Margaret C Hardy; Jonathon Cochrane; Rachel E Allavena
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

5.  Tick killing in situ before removal to prevent allergic and anaphylactic reactions in humans: a cross-sectional study.

Authors:  Benjamin William Phillips Taylor; Andrew Ratchford; Sheryl van Nunen; Brian Burns
Journal:  Asia Pac Allergy       Date:  2019-04-18

6.  Australian Scorpion Hormurus waigiensis Venom Fractions Show Broad Bioactivity Through Modulation of Bio-Impedance and Cytosolic Calcium.

Authors:  David M Housley; Jeremy L Pinyon; Georg von Jonquieres; Chamini J Perera; Michael Smout; Michael J Liddell; Ernest A Jennings; David Wilson; Gary D Housley
Journal:  Biomolecules       Date:  2020-04-16

7.  Scorpion peptides: potential use for new drug development.

Authors:  Bennasr Hmed; Hammami Turky Serria; Zeghal Khaled Mounir
Journal:  J Toxicol       Date:  2013-06-15

Review 8.  Spider-venom peptides as bioinsecticides.

Authors:  Monique J Windley; Volker Herzig; Sławomir A Dziemborowicz; Margaret C Hardy; Glenn F King; Graham M Nicholson
Journal:  Toxins (Basel)       Date:  2012-03-22       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.